Burning Rock Biotech (Burning Rock Biotech) Beginning Cash Position : $85.43 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Beginning Cash Position?

Burning Rock Biotech's Beginning Cash Position for the quarter that ended in Mar. 2024 was $85.43 Mil.

Burning Rock Biotech's quarterly Beginning Cash Position declined from Sep. 2023 ($100.48 Mil) to Dec. 2023 ($89.18 Mil) and declined from Dec. 2023 ($89.18 Mil) to Mar. 2024 ($85.43 Mil).

Burning Rock Biotech's annual Beginning Cash Position declined from Dec. 2021 ($302.26 Mil) to Dec. 2022 ($206.42 Mil) and declined from Dec. 2022 ($206.42 Mil) to Dec. 2023 ($129.59 Mil).

Burning Rock Biotech Beginning Cash Position Historical Data

The historical data trend for Burning Rock Biotech's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Beginning Cash Position Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

13.59

15.02

302.26

206.42

129.59

Burning Rock Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															134.27	112.15	100.48	89.18	85.43

Burning Rock Biotech Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Burning Rock Biotech Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.